Investigations into, and development of, a lyophilized and formulated recombinant human factor IX produced from CHO cells

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biotechnology Letters

• Publication date

  2017-05-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10529-017-2353-yPMID 28484912
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Process cycle development of freeze drying for therapeutic proteins with stability evaluation

  2016cited by this paper
• Efficient expression of functional human coagulation factor IX in stably-transfected Drosophila melanogaster S2 cells; comparison with the mammalian CHO system

  2016cited by this paper
• Practical Considerations for Determination of Glass Transition Temperature of a Maximally Freeze Concentrated Solution

  2016influential reference
• Approaches for recombinant human factor IX production in serum-free suspension cultures

  2016cited by this paper
• The Relevance of Thermal Properties for Improving Formulation and Cycle Development: Application to Freeze-Drying of Proteins

  2016influential reference
• Biotherapeutic protein formulation variables influence protein integrity and can promote post-translational modifications as shown using chicken egg white lysozyme as a model system

  2015cited by this paper
• Anion-exchange purification of recombinant factor IX from cell culture supernatant using different chromatography supports.

  2013cited by this paper
• The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals.

  2011cited by this paper
• Formulation and process development strategies for manufacturing biopharmaceuticals

  2010cited by this paper
• The Effects of Medium Supplement on High-Level Production of Recombinant Human Factor IX in CHO Cell

  2010cited by this paper
• Design of a Formulation for Freeze Drying

  2010influential reference
• Investigating variables and mechanisms that influence protein integrity in low water content amorphous carbohydrate matrices

  2009cited by this paper
• Reformulated BeneFix®: efficacy and safety in previously treated patients with moderately severe to severe haemophilia B

  2007cited by this paper
• Influence of the Active Pharmaceutical Ingredient Concentration on the Physical State of Mannitol—Implications in Freeze-Drying

  2005cited by this paper
• Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice

  2004influential reference
• Optimisation of a freeze-drying process of high purity Factor VIII and Factor IX concentrates

  2003influential reference
• Protein modification during anti‐viral heat‐treatment bioprocessing of factor VIII concentrates, factor IX concentrates, and model proteins in the presence of sucrose

  2002cited by this paper
• Mannitol-sucrose mixtures--versatile formulations for protein lyophilization.

  2002cited by this paper
• Lyophilization and development of solid protein pharmaceuticals.

  2000influential reference
• The formulation of recombinant factor IX: stability, robustness, and convenience.

  1998influential reference

• Lyophilization of pharmaceuticals: an overview and practical approaches for developing the lyophilization cycle

  2025cites this paper
• Amino Acids Stabilizing Effect on Protein and Colloidal Dispersions

  2024cites this paper
• The effect of formulation variables on protein stability and integrity of a model IgG4 monoclonal antibody and translation to formulation of a model ScFv

  2017cites this paper
• 1 1 The effect of formulation variables on protein stability and integrity of a model IgG 4 monoclonal 2 antibody and translation to formulation of a model ScFv 3 4

  year unknowncites this paper